IGC Pharma, Inc. (IGC)

Last Closing Price: 0.49 (2024-05-31)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

IGC Pharma, Inc. (IGC) had Net Income of $-11.51M for the most recently reported fiscal year, ending 2023-03-31.

Figures for fiscal year ending 2023-03-31
Income Statement Financials
$0.91M
Net Income
$-11.51M
$0.47M
$0.44M
$12.48M
$-11.57M
$0.07M
$-11.51M
$-11.51M
$-11.51M
$-11.51M
$-11.51M
$-11.51M
$-11.57M
$-10.91M
52.58M
52.58M
$-0.22
$-0.22
Balance Sheet Financials
$6.47M
$8.21M
$10.71M
$17.18M
$1.90M
$0.14M
$0.37M
$2.27M
$14.91M
$13.74M
$14.91M
53.08M
Cash Flow Statement Financials
$-7.05M
$-0.23M
$0.10M
$10.46M
$3.20M
$-7.26M
$2.84M
--
--
Fundamental Metrics & Ratios
3.41
--
--
0.01
0.01
48.52%
-1270.14%
-1270.14%
-1198.02%
-1263.01%
-1263.01%
$-6.82M
--
--
--
0.05
0.18
8.51
42.87
-77.16%
-83.73%
-66.98%
-76.44%
$0.28
$-0.13
$-0.13